Deborah Schrag

Deborah Schrag

UNVERIFIED PROFILE

Are you Deborah Schrag?   Register this Author

Register author
Deborah Schrag

Deborah Schrag

Publications by authors named "Deborah Schrag"

Are you Deborah Schrag?   Register this Author

100Publications

3024Reads

37Profile Views

Pre-existing autoimmune disease and the risk of immune-related adverse events among patients receiving checkpoint inhibitors for cancer.

Cancer Immunol Immunother 2019 Jun 15;68(6):917-926. Epub 2019 Mar 15.

Division of Population Sciences, Dana-Farber Cancer Institute, 450 Brookline Ave., Boston, MA, 02215, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00262-019-02321-z
Publisher Site
http://dx.doi.org/10.1007/s00262-019-02321-zDOI Listing
June 2019

The Evolving Uses of "Real-World" Data.

JAMA 2019 04;321(14):1359-1360

Associate Editor.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2019.4064DOI Listing
April 2019

The lomustine crisis: awareness and impact of the 1500% price hike.

Neuro Oncol 2019 01;21(1):1-3

Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/noy189DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6303421PMC
January 2019

Oncology in Transition: Changes, Challenges, and Opportunities.

JAMA 2018 12;320(21):2203-2204

University of North Carolina Cancer Center, Chapel Hill.

View Article

Download full-text PDF

Source
http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.20
Publisher Site
http://dx.doi.org/10.1001/jama.2018.17057DOI Listing
December 2018

Survival Disparities by Race and Ethnicity in Early Esophageal Cancer.

Dig Dis Sci 2018 11 14;63(11):2880-2888. Epub 2018 Aug 14.

Institute for Technology Assessment, Massachusetts General Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10620-018-5238-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738563PMC
November 2018

Feasibility of Implementing the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in a Multicenter Trial: NCCTG N1048.

J Clin Oncol 2018 Sep 11:JCO2018788620. Epub 2018 Sep 11.

Ethan Basch, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill; Bryce B. Reeve, Duke Cancer Institute, Duke University Medical Center, Durham, NC; Ethan Basch, Lauren J. Rogak, Mary C. Shaw, Narre Heon, and Martin R. Weiser, Memorial Sloan Kettering Cancer Center, New York, NY; Amylou C. Dueck and Brenda Ginos, Alliance Statistics and Data Center, Mayo Clinic, Scottsdale, AZ; Sandra A. Mitchell, Lori M. Minasian, and Andrea M. Denicoff, National Cancer Institute, Rockville, MD; Jennifer K. Wind, Harvey J. Mamon, and Deborah Schrag, Dana-Farber/Partners CancerCare, Boston, MA; Qian Shi, Garth D. Nelson, and Jeffrey P. Meyers, Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN; George J. Chang, University of Texas MD Anderson Cancer Center, Houston, TX; Tatjana Kolevska, Kaiser Permanente Vallejo Medical Center, Vallejo, CA; and Deborah Watkins Bruner, Emory University, Atlanta, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.78.8620DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209091PMC
September 2018

Medicare Spending for Breast, Prostate, Lung, and Colorectal Cancer Patients in the Year of Diagnosis and Year of Death.

Health Serv Res 2018 08 26;53(4):2118-2132. Epub 2017 Jul 26.

Division of Population Sciences, Dana Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/1475-6773.12745DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6051983PMC
August 2018

Oncology Patient Portal Enrollment at a Comprehensive Cancer Center: A Quality Improvement Initiative.

J Oncol Pract 2018 08;14(8):e451-e461

Dana-Farber/Partners Cancer Care; and Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.17.00008DOI Listing
August 2018

Factors Contributing To Geographic Variation In End-Of-Life Expenditures For Cancer Patients.

Health Aff (Millwood) 2018 07;37(7):1136-1143

Mary Beth Landrum is a professor of health care policy in the Department of Health Care Policy, Harvard Medical School.

View Article

Download full-text PDF

Source
http://www.healthaffairs.org/doi/10.1377/hlthaff.2018.0015
Publisher Site
http://dx.doi.org/10.1377/hlthaff.2018.0015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6059805PMC
July 2018

Well-being beyond the bladder. How do we improve the overall health of patients with bladder cancer?

BJU Int 2018 04;121(4):489-491

Dana Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.14158DOI Listing
April 2018

Lack of Association Between Heart Failure and Incident Cancer.

J Am Coll Cardiol 2018 04;71(14):1501-1510

Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2018.01.069DOI Listing
April 2018

Palliative radiation and fractionation in medicare patients with incurable non-small cell lung cancer.

Adv Radiat Oncol 2018 Jul-Sep;3(3):382-390. Epub 2018 Apr 23.

Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.adro.2018.04.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128034PMC
April 2018

Precision Oncology: Who, How, What, When, and When Not?

Am Soc Clin Oncol Educ Book 2017 ;37:160-169

From the University of Tennessee Health Science Center, Memphis, TN; Levine Cancer Institute, Charlotte, SC; Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_174176DOI Listing
December 2017

Comparative effectiveness of adjuvant chemoradiotherapy after gastrectomy among older patients with gastric adenocarcinoma: a SEER-Medicare study.

Gastric Cancer 2017 Sep 15;20(5):811-824. Epub 2017 Feb 15.

Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10120-017-0693-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557693PMC
September 2017

A stakeholder-driven approach to improve the informed consent process for palliative chemotherapy.

Patient Educ Couns 2017 Aug 22;100(8):1527-1536. Epub 2017 Mar 22.

McGraw Patterson Center for Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pec.2017.03.024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5492511PMC
August 2017

The Impact of a Prior Diagnosis of Barrett's Esophagus on Esophageal Adenocarcinoma Survival.

Am J Gastroenterol 2017 Aug 4;112(8):1256-1264. Epub 2017 Apr 4.

Institute for Technology Assessment, Massachusetts General Hospital, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ajg.2017.82DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5856156PMC
August 2017

Development and Validation of the PREMM Model for Comprehensive Risk Assessment of Lynch Syndrome.

J Clin Oncol 2017 Jul 10;35(19):2165-2172. Epub 2017 May 10.

Fay Kastrinos and Ashley McFarland, Columbia University Medical Center, New York, NY; Hajime Uno, Chinedu Ukaegbu, Matthew B. Yurgelun, Matthew H. Kulke, Deborah Schrag, Jeffrey A. Meyerhardt, Charles S. Fuchs, Robert J. Mayer, Kimmie Ng, and Sapna Syngal, Dana-Farber Cancer Institute; Carmelita Alvero, Harvard T.H. Chan School of Public Health; Matthew B. Yurgelun, Matthew H. Kulke, Deborah Schrag, Jeffrey A. Meyerhardt, Charles S. Fuchs, Robert J. Mayer, Kimmie Ng, and Sapna Syngal, Harvard Medical School; Sapna Syngal, Brigham and Women's Hospital, Boston, MA; and Ewout W. Steyerberg, University Medical Center Rotterdam, Rotterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.69.6120DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493047PMC
July 2017

Delivery of meaningful cancer care: a retrospective cohort study assessing cost and benefit with the ASCO and ESMO frameworks.

Lancet Oncol 2017 07 2;18(7):887-894. Epub 2017 Jun 2.

Departments of Oncology and Public Health Sciences, Queen's University, Kingston, ON, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(17)30415-1DOI Listing
July 2017

Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer.

J Clin Oncol 2017 Apr 30;35(10):1086-1095. Epub 2017 Jan 30.

Matthew B. Yurgelun, Matthew H. Kulke, Charles S. Fuchs, Hajime Uno, Chinedu I. Ukaegbu, Lauren K. Brais, Philip G. McNamara, Robert J. Mayer, Deborah Schrag, Jeffrey A. Meyerhardt, Kimmie Ng, and Sapna Syngal, Dana-Farber Cancer Institute; Matthew B. Yurgelun, Matthew H. Kulke, Charles S. Fuchs, Hajime Uno, Jason L. Hornick, Robert J. Mayer, Deborah Schrag, Jeffrey A. Meyerhardt, Kimmie Ng, and Sapna Syngal, Harvard Medical School; Matthew B. Yurgelun, Matthew H. Kulke, Charles S. Fuchs, Jason L. Hornick, Robert J. Mayer, Deborah Schrag, Jeffrey A. Meyerhardt, Kimmie Ng, and Sapna Syngal, Brigham and Women's Hospital, Boston, MA; and Brian A. Allen, John Kidd, Nanda Singh, Anne-Renee Hartman, and Richard J. Wenstrup, Myriad Genetics, Salt Lake City, UT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.0012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455355PMC
April 2017

Multimodal Rectal Cancer Treatment: In Some Cases, Less May Be More.

Am Soc Clin Oncol Educ Book 2016 ;35:92-102

From the Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Medical Oncology, Mount Vernon Centre for Cancer Treatment, London, United Kingdom; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_159221DOI Listing
January 2017

Association of Regional Intensity of Ductal Carcinoma In Situ Treatment With Likelihood of Breast Preservation.

JAMA Oncol 2017 Jan;3(1):101-104

Division of Population Sciences, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2016.2164DOI Listing
January 2017

Comparative effectiveness of radiotherapy with vs. without temozolomide in older patients with glioblastoma.

J Neurooncol 2017 01 21;131(2):301-311. Epub 2016 Oct 21.

Department of Biostatistics, Harvard School of Public Health, Building 2, 4th Floor, 655 Huntington Ave, Boston, MA, 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-016-2294-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5303537PMC
January 2017

Biosimilar Therapy for ERBB2 (HER2)-Positive Breast Cancer: Close Enough?

JAMA 2017 01;317(1):30-32

Dana-Farber Cancer Institute, Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts2Associate Editor, JAMA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2016.18979DOI Listing
January 2017

Beyond Composite Endpoints Analysis: Semicompeting Risks as an Underutilized Framework for Cancer Research.

J Natl Cancer Inst 2016 12 5;108(12). Epub 2016 Jul 5.

Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA (IJ, SH); Division of Population Sciences, Dana Farber Cancer Institute, Boston, MA (DS); Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN (DJS).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djw154DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241896PMC
December 2016

Neoadjuvant Therapy for Rectal Cancer Affects Lymph Node Yield and Status Without Clear Implications on Outcome: The Case for Eliminating a Metric and Using Preoperative Staging to Guide Therapy.

J Natl Compr Canc Netw 2016 12;14(12):1528-1534

From Division of Surgical Oncology, The Ohio State University Wexner Medical Center/Arthur G. James Cancer Hospital, Columbus, Ohio; Center for Biostatistics, The Ohio State University Wexner Medical Center, Columbus, Ohio; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania; City of Hope Comprehensive Cancer Center, Duarte, California; University of Texas MD Anderson Cancer Center, Houston, Texas; Kalispell Regional Healthcare Specialists, Kalispell Regional Healthcare, Kalispell, Montana; Memorial Sloan Kettering Cancer Center, New York, New York; Dana-Farber Cancer Institute, Boston, Massachusetts; and Depaartment of Medicine, Division of Hematology/Oncology, Mayo Clinic Cancer Center, Phoenix, Arizona.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292039PMC
http://dx.doi.org/10.6004/jnccn.2016.0164DOI Listing
December 2016

Hierarchical models for semi-competing risks data with application to quality of end-of-life care for pancreatic cancer.

J Am Stat Assoc 2016 18;111(515):1075-1095. Epub 2016 Oct 18.

Department of Biostatistics, Harvard T.H. Chan School of Public Health.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/01621459.2016.1164052DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347153PMC
October 2016

Use of a novel statistical technique to examine the delivery of breast cancer follow-up care by different types of oncology providers.

J Eval Clin Pract 2016 Oct 17;22(5):737-44. Epub 2016 Mar 17.

Wisconsin Surgical Outcomes Research Program, Department of Surgery, UW Madison School of Medicine and Public Health, Madison, WI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jep.12529DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5026853PMC
October 2016

Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received.

J Clin Oncol 2016 08 31;34(24):2925-34. Epub 2016 May 31.

Lowell E. Schnipper, Beth Israel Deaconess Medical Center, Harvard Medical School; Therese Mulvey and Jeffrey Peppercorn, Massachusetts General Hospital; Deborah Schrag, Dana-Farber Cancer Institute, Boston, MA; Nancy E. Davidson, University of Pittsburgh Cancer Institute and University of Pittsburgh Medical Center Cancer Center, Pittsburgh; Adam P. Dicker, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA; Dana S. Wollins and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; Douglas W. Blayney, Stanford University Medical Center, Stanford; Patricia A. Ganz, Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles; Peter P. Yu, Palo Alto Medical Foundation, Palo Alto, CA; J. Russell Hoverman, Texas Oncology, Dallas, TX; Robert Langdon, Nebraska Cancer Specialists; Julie M. Vose, University of Nebraska Medical Center, Omaha, NE; Gary H. Lyman, Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA; Neal J. Meropol, University Hospitals Case Medical Center Seidman Cancer Center, Case Comprehensive Cancer Center, and Case Western Reserve University, Cleveland, OH; Lee Newcomer, UnitedHealthcare, Minneapolis, MN; Blase Polite, University of Chicago Medicine, Chicago, IL; Derek Raghavan, Levine Cancer Institute, Charlotte, NC; Gregory Rossi, AstraZeneca, Macclesfield, United Kingdom; Leonard Saltz and Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY; and Thomas J. Smith, Sidney Kimmel Cancer Center, Johns Hopkins University, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.68.2518DOI Listing
August 2016

Racial/Ethnic and Socioeconomic Differences in Colorectal and Breast Cancer Treatment Quality: The Role of Physician-level Variations in Care.

Med Care 2016 08;54(8):780-8

*Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine, Los Angeles, CA †Division of Population Sciences, Dana Farber Cancer Institute and the Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MLR.0000000000000561DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173517PMC
August 2016

Living in a material world: tumor-treating fields at the top of the charts.

Neuro Oncol 2016 08;18(8):1033-4

University of Virginia Neuro-Oncology Center, Charlottesville, Virginia (D. Schiff); Dana-Farber Cancer Institute, Boston, Massachusetts (D. Schrag).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/now138DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933493PMC
August 2016

Effects of state-level medicaid policies and patient characteristics on time to breast cancer surgery among medicaid beneficiaries.

Breast Cancer Res Treat 2016 08 15;158(3):573-81. Epub 2016 Jul 15.

Dana Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-016-3879-8DOI Listing
August 2016

Identifying cancer patients who alter care or lifestyle due to treatment-related financial distress.

Psychooncology 2016 06 7;25(6):719-25. Epub 2015 Jul 7.

Division of Medical Oncology, Department of Medicine, DUMC, Durham, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pon.3911DOI Listing
June 2016

Feasibility and clinical impact of sharing patient-reported symptom toxicities and performance status with clinical investigators during a phase 2 cancer treatment trial.

Clin Trials 2016 06 4;13(3):331-7. Epub 2015 Nov 4.

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1740774515615540DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5228492PMC
June 2016

Reimbursing Wisely? CMS's Trial of Medicare Part B Drug Payment Reform.

Authors:
Deborah Schrag

N Engl J Med 2016 Jun;374(22):2101-5

From the Dana-Farber Cancer Institute, Boston.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMp1603735DOI Listing
June 2016

Association of Financial Strain With Symptom Burden and Quality of Life for Patients With Lung or Colorectal Cancer.

J Clin Oncol 2016 05 29;34(15):1732-40. Epub 2016 Feb 29.

Christopher S. Lathan, Angel Cronin, Reginald Tucker-Seeley, and Deborah Schrag, Dana-Farber Cancer Institute, Boston, MA; S. Yousuf Zafar, Duke University School of Medicine; John Z. Ayanian, University of Michigan; and Reginald Tucker-Seeley, Harvard T.H. Chan School of Public Health.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.2232DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966336PMC
May 2016

Optimizing Treatment for Locally Advanced Pancreas Cancer: Progress but No Precision.

Authors:
Deborah Schrag

JAMA 2016 May;315(17):1837-8

Dana Farber Cancer Institute, Boston, Massachusetts2Associate Editor, JAMA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2016.4284DOI Listing
May 2016

Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies: a cost-effectiveness analysis.

Gut 2016 Apr 16;65(4):563-74. Epub 2015 Mar 16.

Center for Health Decision Science, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://gut.bmj.com/lookup/doi/10.1136/gutjnl-2014-308588
Publisher Site
http://dx.doi.org/10.1136/gutjnl-2014-308588DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4573370PMC
April 2016

Locally advanced rectal cancer: time for precision therapeutics.

Am Soc Clin Oncol Educ Book 2015 :e192-6

From the Memorial Sloan Kettering Cancer Center, New York, NY; Shanghai Cancer Center, Fudan University, Shanghai, China; Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14694/EdBook_AM.2015.35.e192DOI Listing
February 2016

Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial.

J Clin Oncol 2016 Feb 7;34(6):557-65. Epub 2015 Dec 7.

Ethan Basch, Mark G. Kris, Howard I. Scher, Clifford A. Hudis, Paul Sabbatini, Lauren Rogak, Thomas M. Atkinson, Joanne F. Chou, Dorothy Dulko, Laura Sit, Michael Fruscione, and Deborah Schrag, Memorial Sloan Kettering Cancer Center, New York, NY; Ethan Basch, Allison M. Deal, and Antonia V. Bennett, University of North Carolina, Chapel Hill, NC; Amylou C. Dueck, Mayo Clinic, Scottsdale, AZ; Allison Barz, Children's Hospital of Philadelphia, Philadelphia, PA; Paul Novotny and Jeff A. Sloan, Mayo Clinic, Rochester, MN; and Deborah Schrag, Dana-Farber/Harvard Cancer Center, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.0830DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872028PMC
February 2016

High Intensity of End-of-Life Care Among Adolescent and Young Adult Cancer Patients in the New York State Medicaid Program.

Med Care 2015 Dec;53(12):1018-26

*Department of Pediatric Oncology †The Division of Population Sciences' Center for Outcomes and Policy Research, Dana-Farber Cancer Institute ‡Division of Pediatric Hematology/Oncology, Children's Hospital, Boston, MA §New York State Department of Health, State Cancer Registry ∥New York State Department of Health, Office of Quality and Patient Safety, Albany, NY ¶Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/MLR.0000000000000437DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4648674PMC
December 2015

Outcomes of Prognostic Disclosure: Associations With Prognostic Understanding, Distress, and Relationship With Physician Among Patients With Advanced Cancer.

J Clin Oncol 2015 Nov 5;33(32):3809-16. Epub 2015 Oct 5.

Andrea C. Enzinger and Deborah Schrag, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and Baohui Zhang and Holly G. Prigerson, Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.61.9239DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737862PMC
November 2015

American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options.

J Clin Oncol 2015 Aug 22;33(23):2563-77. Epub 2015 Jun 22.

Lowell E. Schnipper, Beth Israel Deaconess Medical Center, Harvard Medical School; Jeffrey Peppercorn, Massachusetts General Hospital; Deborah Schrag, Dana-Farber Cancer Institute, Boston; Therese Mulvey, Southcoast Centers for Cancer Care, Fall River, MA; Nancy E. Davidson, University of Pittsburgh Cancer Institute and University of Pittsburgh Medical Center Cancer Center, Pittsburgh; Adam P. Dicker, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA; Dana S. Wollins, Courtney Tyne, and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; Douglas W. Blayney, Stanford University Medical Center, Stanford; Patricia A. Ganz, Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles; Peter P. Yu, Palo Alto Medical Foundation, Palo Alto, CA; Diane Blum, National Executive Service Corps; Leonard Saltz and Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY; J. Russell Hoverman, Texas Oncology, Dallas, TX; Robert Langdon, Nebraska Cancer Specialists, Omaha, NE; Gary H. Lyman, Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA; Neal J. Meropol, University Hospitals Case Medical Center Seidman Cancer Center, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH; Lee Newcomer, UnitedHealthcare, Minneapolis, MN; Blase Polite, University of Chicago Medicine, Chicago, IL; Derek Raghavan, Levine Cancer Institute, Charlotte, NC; Gregory Rossi, AstraZeneca, Macclesfield, Cheshire, United Kingdom; and Thomas J. Smith, Sidney Kimmel Cancer Center, Johns Hopkins University, Baltimore, MD.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2015.61.6706
Publisher Site
http://dx.doi.org/10.1200/JCO.2015.61.6706DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015427PMC
August 2015

Catalog and comparison of societal preferences (utilities) for lung cancer health states: results from the Cancer Care Outcomes Research and Surveillance (CanCORS) study.

Med Decis Making 2015 04 10;35(3):371-87. Epub 2015 Feb 10.

Institute for Technology Assessment, Massachusetts General Hospital, Boston, MA (ACT, MCM, JSS, PMM)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0272989X15570364DOI Listing
April 2015

Clinician perspectives on potentially avoidable hospitalizations in patients with cancer.

JAMA Oncol 2015 Apr;1(1):109-110

Dana-Farber Cancer Institute and Harvard Medical School, both in Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2014.155DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486301PMC
April 2015

Leveraging state cancer registries to measure and improve the quality of cancer care: a potential strategy for California and beyond.

J Natl Cancer Inst 2015 Mar 11;107(5). Epub 2015 Mar 11.

Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA (RAH, CGT); Stanford Cancer Institute, Stanford University, Stanford, CA (DWB); Preventive Medicine, Division of Epidemiology, University of Southern California, Los Angeles, CA (DD); Department of Pathology and Laboratory Medicine (MH) and Institute for Population Health Improvement (KWK), University of California Davis, Sacramento, CA; Department of Health Policy and Management, Rollins School of Public Health, Winship Cancer Institute, Emory University, Atlanta, GA (JL); Oncology and Care Management, WellPoint, Inc., Thousand Oaks, CA (JM); Hooper, Lundy & Bookman, P.C., San Francisco, CA (SKP); Consumer Reports Health, Yonkers, NY (JS); Department of Medicine, Harvard Medical School/Dana Farber Cancer Institute, Boston, MA (DS).

View Article

Download full-text PDF

Source
http://jnci.oxfordjournals.org/content/107/5/djv047.full.pdf
Web Search
http://jnci.oxfordjournals.org/cgi/doi/10.1093/jnci/djv047
Publisher Site
http://dx.doi.org/10.1093/jnci/djv047DOI Listing
March 2015

Bayesian Semi-parametric Analysis of Semi-competing Risks Data: Investigating Hospital Readmission after a Pancreatic Cancer Diagnosis.

J R Stat Soc Ser C Appl Stat 2015 02;64(2):253-273

Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/rssc.12078DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427057PMC
February 2015

Incidence of minimally invasive colorectal cancer surgery at National Comprehensive Cancer Network centers.

J Natl Cancer Inst 2015 Jan 19;107(1):362. Epub 2014 Dec 19.

Memorial Sloan Kettering Cancer Center, New York, NY (HY, MRW); City of Hope Comprehensive Cancer Center, Duarte, CA (JN, AtV, LL, DS); Dana-Farber/Brigham and Women's Cancer Center, Boston, MA (DM, LL); The Ohio State University Comprehensive Cancer Center-James Cancer Hospital and Solove Research Institute, Columbus, OH (TBS); Fox Chase Cancer Center, Philadelphia, PA (JMF); The University of Texas M.D. Anderson Cancer Center, Houston, TX (JMS); Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL (WS Jr); Roswell Park Cancer Institute, Buffalo, NY (NW).

View Article

Download full-text PDF

Source
https://academic.oup.com/jnci/article-lookup/doi/10.1093/jnc
Publisher Site
http://dx.doi.org/10.1093/jnci/dju362DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4296195PMC
January 2015

Comparative effectiveness of intensity-modulated versus 3D conformal radiation therapy among medicare patients with stage III lung cancer.

J Thorac Oncol 2014 Dec;9(12):1788-95

*Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA; and †Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000331DOI Listing
December 2014

Derivation and validation of the SEER-Medicare myelodysplastic syndromes risk score (SMMRS).

Leuk Res 2014 Dec 30;38(12):1420-4. Epub 2014 Sep 30.

Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Center for Leukemia, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2014.09.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314368PMC
December 2014

Characterization and treatment of local recurrence following breast conservation for ductal carcinoma in situ.

Ann Surg Oncol 2014 Nov 24;21(12):3766-73. Epub 2014 May 24.

Wisconsin Surgical Outcomes Research (WiSOR) Program, Department of Surgery, University of Wisconsin Hospitals and Clinics, Madison, WI, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-014-3802-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539255PMC
November 2014

Evaluation of the duplication of staging CT scans for localized colon cancer in a Medicare population.

Med Care 2014 Nov;52(11):963-8

*Department of Epidemiology, Harvard School of Public Health †Dana Farber Cancer Institute ‡Department of Biostatistics, Harvard School of Public Health §Harvard-MIT Division of Health Sciences and Technology, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MLR.0000000000000231DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4197077PMC
November 2014

Discussions about clinical trials among patients with newly diagnosed lung and colorectal cancer.

J Natl Cancer Inst 2014 Oct 13;106(10). Epub 2014 Sep 13.

Division of General Internal Medicine, Brigham and Women's Hospital, Boston, MA (KLK, NLK); Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD (NKA, SBC, CNK); Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA (DS); Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, MI (JZA); University of California, Los Angeles and RAND Corporation, Santa Monica, CA (KK); Department of Population Medicine (RHF) and Department of Health Care Policy (NLK, JZA), Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju216DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4168309PMC
October 2014

Acute hospital care is the chief driver of regional spending variation in Medicare patients with advanced cancer.

Health Aff (Millwood) 2014 Oct;33(10):1793-800

Deborah Schrag is a professor of medicine at Harvard Medical School and a research scientist at the Dana-Farber Cancer Institute.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1377/hlthaff.2014.0280DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203442PMC
October 2014

Physicians' beliefs about the benefits and risks of adjuvant therapies for stage II and stage III colorectal cancer.

J Oncol Pract 2014 Sep 1;10(5):e360-7. Epub 2014 Jul 1.

University of Chicago, Chicago, IL; College of the Holy Cross, Worcester, MA; Dana-Farber Cancer Institute; Brigham and Women's Hospital and Harvard Medical School, Boston, MA; RAND; University of California at Los Angeles, Los Angeles, CA; Memorial Sloan-Kettering Cancer Center, New York, NY; University of Iowa College of Public Health; Veterans Affairs Center for Comprehensive Access and Delivery Research and Evaluation, Iowa City, IA; and Temple University School of Medicine, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2013.001309DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161733PMC
September 2014

Measuring the effectiveness of androgen-deprivation therapy for prostate cancer in the medicare population: adequate data are neither the same as nor the enemy of perfect data.

JAMA Intern Med 2014 Sep;174(9):1468-9

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamainternmed.2014.1107DOI Listing
September 2014

Limited validity of diagnosis codes in Medicare claims for identifying cancer metastases and inferring stage.

Ann Epidemiol 2014 Sep 3;24(9):666-72, 672.e1-2. Epub 2014 Jul 3.

Health Services and Economics Branch, Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.annepidem.2014.06.099DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4135357PMC
September 2014

Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE).

J Natl Cancer Inst 2014 Sep 29;106(9). Epub 2014 Sep 29.

: Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC (EB, BBR, AVB); Department of Health Policy and Management, Gillings School of Public Health, University of North Carolina, Chapel Hill, NC (EB, BBR, AVB); Department of Epidemiology and Biostatistics, Health Outcomes Research Group (EB, LS, LR) and Department of Psychiatry and Behavioral Sciences (JH, TMA), Memorial Sloan Kettering Cancer Center, New York, NY; Outcomes Research Branch, Applied Research Program, Division of Cancer Control and Population Sciences (SAM, SBC), Division of Cancer Prevention (LMM), NCTN Clinical Trials Operations, Cancer Therapy Evaluation Program (AD), Community Oncology and Prevention Trials Research Group, Division of Cancer Prevention (AMO, DSG, JK), and Investigational Drug Branch, Cancer Therapy Evaluation Program (AC), National Cancer institute, Bethesda, MD;Division of Health Sciences Research, College of Medicine, Mayo Clinic - Arizona, Scottsdale, AZ (ACD); Department of Symptom Research, Division of Internal Medicine, The University of Texas Anderson Cancer Center, Houston, TX (TRM, CSC); Patient Advocate, New York, NY (DBP); Department of Medicine, Duke Center for Learning HealthCare, Duke Cancer Research Program, Duke University, Durham, NC (APA); Nell Hodgson Woodruff School of Nursing, Winship Cancer Institute of Emory University, Emory University, Atlanta, GA (DWB); Mayo Clinic - Rochester, Rochester, MN (JAS); SemanticBits LLC, Herndon, VA (RC, PB); Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA (AB); Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA (DS).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju244DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200059PMC
September 2014

Moving beyond the hazard ratio in quantifying the between-group difference in survival analysis.

J Clin Oncol 2014 Aug 30;32(22):2380-5. Epub 2014 Jun 30.

Hajime Uno, Deborah Schrag, and Susanna Jacobus, Dana-Farber Cancer Institute; Brian Claggett, Hicham Skali, and Scott Solomon, Harvard Medical School, Brigham and Women's Hospital; Michael Hughes and Lee-Jen Wei, Harvard School of Public Health, Boston, MA; Lu Tian, Stanford University School of Medicine, Palo Alto, CA; Eisuke Inoue and Masahiro Takeuchi, Kitasato University; Toshio Miyata, Health and Global Policy Institute; Yoshiaki Uyama, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan; Paul Gallo, Novartis Pharmaceuticals, East Hanover, NJ; Lihui Zhao, Northwestern University Feinberg School of Medicine, Chicago, IL; and Milton Packer, University of Texas Southwestern Medical Center, Dallas, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.55.2208DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4105489PMC
August 2014

Systemic therapy for advanced appendiceal adenocarcinoma: an analysis from the NCCN Oncology Outcomes Database for colorectal cancer.

J Natl Compr Canc Netw 2014 Aug;12(8):1123-30

From Fox Chase Cancer Center, Philadelphia, Pennsylvania; City of Hope Comprehensive Cancer Center, Duarte, California; Dana-Farber Cancer Institute, Boston, Massachusetts; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, Ohio; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois; The University of Texas MD Anderson Cancer Center, Houston, Texas; Memorial Sloan Kettering Cancer Center, New York, New York; and Roswell Park Cancer Institute, Buffalo, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2014.0109DOI Listing
August 2014